Colon-specific drug delivery for mebeverine hydrochloride

Journal of Drug Targeting

Volumn 15, Issue 10, 2007, Pages 691-700

  Omar, Samia ^a   Aldosari, Basmah ^a   Refai, Hanan ^b   Al Gohary, Omaimah ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Colon targeting; Colon specific drug delivery; Mebeverine Hydrochloride CODES ; Modified CODES containing microspheres; Polysaccharides

Indexed keywords

BARIUM SULFATE; EUDRAGIT; EUDRAGIT E100; EUDRAGIT L100; GLUCOSE OXIDASE; LACTULOSE; MEBEVERINE; MICROSPHERE; POLYMER; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COLON; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SPECIFICITY; DRUG TARGETING; DUODENUM PH; ENTERIC COATED TABLET; ENTEROBACTERIACEAE; GUINEA PIG; IN VIVO STUDY; INFRARED SPECTROSCOPY; INTESTINE FLUID; NONHUMAN; PH; PRIORITY JOURNAL; SIMULATION; STOMACH PH; SUSTAINED DRUG RELEASE; TABLET; TABLET DISINTEGRATION; TECHNOLOGY; X RAY;

ANIMALS; COLON; DRUG DELIVERY SYSTEMS; GUINEA PIGS; HYDROGEN-ION CONCENTRATION; MICROSPHERES; PHENETHYLAMINES; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; TABLETS;

EID: 36749064579     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701603281     Document Type: Article

References (39)

1. Bai, JPF (1995) Colonic delivery of peptide and protein drugs: Consideration of intracellular proteolytic enzymes. STP Pharm Sci, 5, pp. 30-35.
2. Bayomi, MA, Khidr, SH, Abd-Elhady, SS and Al-Angary, AA (1994) Formulation, in vitro and in vivo evaluation of sustained release mebeverine hydrochloride microspheres. Pharm Ind, 56, pp. 192-194.
3. Chang, RK and Rudnic, EM (1991) The effect of various polymeric coating systems on the dissolution and tableting properties of potassium chloride microcapsules. Int J Pharm, 70, pp. 261-270.
4. Davis, SS, Hardy, JG and Fara, JW (1986) Transit of pharmaceutical dosage forms through the small intestine. Gut, 27, pp. 886-892.
5. Dickinson, RG, Baker, PV, Franklin, ME and Hooper, WD (2006) Facile hydrolysis of mebeverine in vitro and in vivo: Negligible circulating concentrations of the drug after oral administration. J Pharm Sci, 80, pp. 952-957.
6. Edwards, C. (1996) Physiology of the colorectal barrier. Adv Drug Deliv Rev, 28, pp. 173-190.
7. Fujino, S., Hiwatashi, N., Sato, K., Imai, H., Akazawa, T. and Ogawa, K. (1995) Socioeconomic evaluations on drug treatment for inflammatory bowel disease (IBD)-Effect of a controlled-release mesalazine tablet (N-5ASA). Rinshoiyaku, 11, pp. 1357-1380.
8. Fukui, E., Miyamura, N., Uemura, K. and Kobayashi, M. (2000) Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int J Pharm, 204, pp. 7-15.
9. Gazzania, A., Imartino, P., Maffione, G. and Sangalli, ME (1994) Oral delayed-release system for colonic specific delivery. Int J Pharm, 108, pp. 77-83.
10. Gorbach, SL (1971) Intestinal microflora. Gastroenterology, 60, pp. 1110-1129.
11. Herrmann, J. and Bodmeier, R. (1998) Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. Eur J Pharm Biopharm, 45, pp. 75-82.
12. Kanao, M., Hashizume, T., Chikawa, Y., Irie, K. and Isoda, S. (1982) Spasmolytic agents. 2. 1,2,3,4-Tetrahydro-2-naphthylamine derivatives. J Med Chem, 25, pp. 1358-1363.
13. Katsuma, M., Watanabe, S., Kawai, H., Takemura, S., Masuda, Y. and Fukui, M. (2002) Studies on lactulose formulations for colon-specific drug delivery. Int J Pharm, 249, pp. 33-43.
14. Khan, MZI, Prebeg, Z. and Kurjakovi, CN (1999) A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug release using Eudragit® L100-55 and Eudragit® S100 combinations. J Control Release, 58, pp. 215-222.
15. Kilicarsan, M. and Baykara, T. (2003) The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm, 252, pp. 99-109.
16. Kimura, T., Sudo, K., Kanzaki, Y., Miki, K., Takeichi, Y., Kurosaki, Y. and Nakayama, T. (1994) Drug absorption from large intestine: Physicochemical factors governing drug absorption. Biol Pharm Bull, 17, pp. 327-333.
17. Kopecek, JP, Kopeckova, H., Brondsted, R., Rathi, B., Rihova, YPY and Ikesue, K. (1992) Polymers for colon-specific drug delivery. J Control Release, 19, pp. 121-130.
18. Langguth, P., Bohner, V., Heizmann, J., Merkle, HP, Wolffram, S., Amidon, GL and Yamashita, S. (1997) The challenge of proteolytic enzymes in intestinal peptide delivery. J Control Release, 46, pp. 39-57.
19. Macfarlane, GT and Cummings, JH (1991) The colonic flora, fermentation and large bowel digestive function. The large intestine: Physiology, pathophysiology and disease, pp. 51-92. Raven press, New York
20. Prasad, YVR, Krishnaiah, YSR and Satyanarayana, S. (1998) In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Release, 51:2, pp. 281-287.
21. Rao, S. and Ritschel, WA (1995) Colonic drug delivery of small peptides. STP Pharm Sci, 5, pp. 19-29.
22. Rubenstein, A., Radai, R., Ezra, M., Pathak, S. and Rokem, JS (1993) In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier. Pharm Res, 10, pp. 258-263.
23. Rubinstein, A., Tirosh, B., Baluom, M., Nassar, T., David, A., Radai, R., Gliko-Kabir, I. and Friedman, M. (1997) The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J Control Release, 46, pp. 59-73.
24. Sayed, AMH and Price, JC (1986) Tablet properties and dissolution characteristics of compressed cellulose acetate butyrate microcapsules containing succinyl sulfathiazole. Drug Dev Ind Pharm, 12, pp. 577-587.
25. Shantha, KL, Ravichandran, P. and Rao, KP (1995) Azo polymeric hydrogels for colon targeted drug delivery. Biomaterials, 16, pp. 1313-1318.
26. Sinha, VR and Kumria, R. (2001) Polysaccharides in colon-specific drug delivery. Int J Pharm, 224, pp. 19-38.
27. Sinha, VR, Mittal, BR and Kumria, R. (2005) In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm, 289:1, pp. 79-85.
28. Steed, KP, Hooper, G., Monti, N., Benedetti, MS, Fornasini, G. and Wilding, IR (1997) The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system ("TIME CLOCK®" system). J Control Release, 49, pp. 115-122.
29. +-induced contraction of rat intestine in vivo. Eur J Pharmacol, 96, pp. 295-301.
30. Sveinsson, SJ, Kristmundsdottir, T. and Ingvarsdottir, K. (1993) The effect of tableting on the release characteristics of naproxen and ibuprofen microcapsules. Int J Pharm, 92, pp. 29-34.
31. Takemura, S., Watanabe, S., Katsuma, M. and Fukui, M. (2000) Human Gastrointestinal transit study of a novel colon delivery system (CODES™) using γ-scintigraphy. Proc Int Symp Control Rel Bioact Mater, 27, pp. 445-446.
32. Tayade, PT and Kale, RD (2004) Encapsulation of water-insoluble drug by a cross-linking technique: Effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate. AAPS Pharm Sci, 6, pp. 1-8.
33. Terada, A., Hara, H., Kataoka, M. and Mitsuoka, T. (1992) Effect of lactulose on the composition and metabolic activity of the human faecal flora. Microb Ecol Health Dis, 5, pp. 43-50.
34. Vandamme, TF, Lenourry, A., Charrueau, C. and Chaumeil, JC (2002) The use of polysaccharides to target drugs to the colon. Carbohydr Polym, 48, pp. 219-231.
35. Wagener, S., Shankar, KR, Turnock, RR, Lamont, GL and Baillie, CT (2004) Colonic transit time -what is normal?. J Pediatr Surg, 39, pp. 166-169.
36. Wong, D., Larrabee, S., Clifford, K., Tremblay, J. and Driend, DR (1997) Dissolution apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulations. J Control Release, 47, pp. 173-179.
37. Wu, PC, Huang, YB, Chang, JS, Tsai, MJ and Tsai, YH (2003) Design and evaluation of sustained release microspheres of potassium chloride prepared by Eudragit®. Eur J Pharm Sci, 19:115, p. 122.
38. Yamaoka, T., Makita, Y., Sasatani, H., Kim, SI and Kimura, Y. (2000) Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: Its properties, degradation behavior, and utilization for drug formulation. J Control Release, 66, pp. 187-197.
39. Yang, L., Chu, JS and Fix, J. (2002) Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm, 235, pp. 1-15.